Following the March 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this updated NENC wide guideline which has been developed to replace the previous version by the Northern Region Gender Dysphoria Service.

All comments will be reviewed but please do not expect a personal reply as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.

Please note

1.    The messages sent from this form are transmitted via our host’s web server. If you have any security concerns about this process you can send your comments/feedback using your own email client to nuth.nyrdtc.rxsupp@nhs.net

2.    This consultation has been extended and closes at 5pm on Tuesday 23rd April 2024

Title Documents Decision Date

New

13/03/2024
General Guidelines For The Use Of Hormone Treatment In Gender Dysphoria 052 General Guidelines For The Use Of Hormone Treatment In Gender Dysphoria - Northern Region Gender Dysphoria Service draft feb 2024